
Investible is an early-stage venture capital firm backing technology startups across the Asia-Pacific region and beyond. The firm operates multiple funds including a sector-agnostic early-stage fund and a dedicated Climate Tech Fund, investing from pre-seed through Series A.
Deal activity increased 100% year-over-year (4 deals in the last 12 months). Their most common stage is seed (44% of deals). Average disclosed round size is $5.8M (across 53 rounds with reported amounts).
Portfolio
63
Fund Size
—
Top Stage
Seed
Last 12 Mo
6
Team
Peter Trent
Non-Executive Director
Ben Lindsay
Investment Principal
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
73 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Seed | $1.9M | Aug 2026 | |
| Seed | $4M | Aug 2026 | |
| Series A | $20M | Mar 2026 | |
| Series B | — | Mar 2026 | |
| Series B | — | Nov 2025 | |
| Pre-Seed | $2M | Oct 2025 | |
| NNRN (National Renewable Network) | Series A | $67.2M | Aug 2025 |
| VVoltavate | Pre-Seed | $3.5M | Jun 2025 |
| RRevibe | Series A | $17M | Jan 2025 |
| Series A | $20M | Jan 2025 | |
| Seed | $4M | Oct 2024 | |
| Pre-Seed | — | Feb 2024 | |
| Series A | $1.6M | Jan 2024 | |
| Bridge | $3M | Jan 2024 | |
| VVeyor | Series A | $2.8M | Jan 2024 |
| Series A | $10.5M | Jan 2024 | |
| Seed | — | Oct 2023 | |
| Seed | $1.6M | Sep 2023 | |
| Seed | $3.3M | Jun 2023 | |
| Pre-Seed | $1.9M | May 2023 | |
| Seed | $1.6M | Apr 2023 | |
| FFingerprint For Success | Seed | — | Jan 2023 |
| Seed | $1.5M | Jan 2023 | |
| Seed | — | Jan 2023 | |
| Seed | $3M | Jan 2023 |
Page 1 of 3
Top Co-Investors
Artesian4 shared
OIF Ventures4 shared
Vulpes3 shared
Plug and Play Tech Center3 shared
Startmate3 shared
Gobi Partners3 shared
BEENEXT3 shared
Twynam2 shared
UniQuest2 shared
FTW Ventures2 shared
Closed Loop Partners2 shared
In-Q-Tel2 shared
Understorey2 shared
Main Sequence2 shared
Galileo Ventures2 shared
Clean Energy Finance Corporation2 shared
Virescent Ventures2 shared
B Capital2 shared
Oncology Ventures2 shared
Last updated: 8 September 2026